Hangzhou Tigermed Consulting Co Ltd
SZSE:300347

Watchlist Manager
Hangzhou Tigermed Consulting Co Ltd Logo
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Watchlist
Price: 48.8 CNY 2.65%
Market Cap: ¥42B

Relative Value

The Relative Value of one Hangzhou Tigermed Consulting Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 48.8 CNY, Hangzhou Tigermed Consulting Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Hangzhou Tigermed Consulting Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Hangzhou Tigermed Consulting Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
40.6B CNY 6.4 68.1 79.7 79.7
US
PerkinElmer Inc
LSE:0KHE
961.5B USD 336.6 3 986.1 1 142.2 2 199.5
US
Thermo Fisher Scientific Inc
NYSE:TMO
184.5B USD 4.1 27.5 19.1 25.7
US
Danaher Corp
NYSE:DHR
134.4B USD 5.5 37.2 18.9 27.5
KR
Samsung Biologics Co Ltd
KRX:207940
82.3T KRW 18.1 46.1 30.1 39.4
CH
Lonza Group AG
SIX:LONN
32.1B CHF 5.1 34.8 26 26
CN
WuXi AppTec Co Ltd
SSE:603259
268B CNY 6 17.9 18 18
US
Agilent Technologies Inc
NYSE:A
32.3B USD 4.6 25 18.4 21.8
US
Waters Corp
NYSE:WAT
29.6B USD 9.3 46 29.7 37.4
US
IQVIA Holdings Inc
NYSE:IQV
28.2B USD 1.7 20.8 11.7 17.5
US
Mettler-Toledo International Inc
NYSE:MTD
25.7B USD 6.4 29.6 22 24.4
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett